Unknown

Dataset Information

0

Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells.


ABSTRACT: Chronic myeloid leukemia (CML) originates in a hematopoietic stem cell (HSC) transformed by the breakpoint cluster region (BCR)-abelson (ABL) oncogene and is effectively treated with tyrosine kinase inhibitors (TKIs). TKIs do not eliminate disease-propagating leukemic stem cells (LSCs), suggesting a deeper understanding of niche-dependent regulation of CML LSCs is required to eradicate disease. Cxcl12 is expressed in bone marrow niches and controls HSC maintenance, and here, we show that targeted deletion of Cxcl12 from mesenchymal stromal cells (MSCs) reduces normal HSC numbers but promotes LSC expansion by increasing self-renewing cell divisions, possibly through enhanced Ezh2 activity. In contrast, endothelial cell-specific Cxcl12 deletion decreases LSC proliferation, suggesting niche-specific effects. During CML development, abnormal clusters of colocalized MSCs and LSCs form but disappear upon Cxcl12 deletion. Moreover, MSC-specific deletion of Cxcl12 increases LSC elimination by TKI treatment. These findings highlight a critical role of niche-specific effects of Cxcl12 expression in maintaining quiescence of TKI-resistant LSC populations.

SUBMITTER: Agarwal P 

PROVIDER: S-EPMC6499704 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells.

Agarwal Puneet P   Isringhausen Stephan S   Li Hui H   Paterson Andrew J AJ   He Jianbo J   Gomariz Álvaro Á   Nagasawa Takashi T   Nombela-Arrieta César C   Bhatia Ravi R  

Cell stem cell 20190321 5


Chronic myeloid leukemia (CML) originates in a hematopoietic stem cell (HSC) transformed by the breakpoint cluster region (BCR)-abelson (ABL) oncogene and is effectively treated with tyrosine kinase inhibitors (TKIs). TKIs do not eliminate disease-propagating leukemic stem cells (LSCs), suggesting a deeper understanding of niche-dependent regulation of CML LSCs is required to eradicate disease. Cxcl12 is expressed in bone marrow niches and controls HSC maintenance, and here, we show that targete  ...[more]

Similar Datasets

2019-04-02 | GSE124125 | GEO
| PRJNA510808 | ENA
| S-EPMC3605795 | biostudies-literature
| S-EPMC7866198 | biostudies-literature
| S-EPMC5528460 | biostudies-other
| S-EPMC5965294 | biostudies-literature
| S-SCDT-EMBOR-2018-47546-T | biostudies-other
| S-EPMC4478168 | biostudies-literature
| S-EPMC5702939 | biostudies-literature
| S-EPMC5442759 | biostudies-literature